Stakeholder Insight: Acute Coronary Syndromes Fresh look at ACS in Europe, what is the real picture

Questions: Discounts, Updates etc.

Price: $30,400.00

Publication Date: 2007-12-26

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

The face of Acute Coronary Syndrome is changing. The ageing population and pressure of growing risk factors have made a significant impact on the management strategies in Acute Coronary Syndrome . This report unveils the true picture through in-depth analysis of data on over 21,000 ACS patient records in the 5 major European pharmaceutical markets (5EU; France, Germany, Italy, Spain and the UK).


Scope

  • What are the current definitions, diagnostic methods and treatment approaches of the disease?
  • To what extent are reperfusion therapies, such as PCI (percutaneous coronary intervention) and/or thrombolysis, used?
  • What is the current role of pre-hospital thrombolysis and how is this likely to change in the future?
  • What are the current hospital admission and logistics issues?


    • Report Highlights
    Costs are no longer the restraining or dominant driver of a specific pharmacological strategy. Datamonitor's findings show that the routine use of troponins as cardiac markers has aided this development, with almost 90% of all Acute Coronary Syndromes patients receiving tests for either troponin I or troponin T across the 5EU.

    A new definition for myocardial infarction has shifted a significant number of patients from unclear diagnosis of unstable angina to myocardial infarction moving from an essentially conservative and observational approach to an increase in more aggressive treatment strategies.

    Advances in novel imaging techniques provide opportunities to diagnose and treat the most complex Acute Coronary Syndrome cases, however, inter-hospital logistics, necessary specialist training and cost constraints continue to prevent hospitals and clinicians from regular use of those diagnostic methods.


    Reasons to Purchase

  • Understand current definitions, diagnostic methods and treatment approaches in Acute Coronary Syndrome
  • Quantify current dynamics of hospital logistics, conservative therapies and reperfusion therapies, such as PCI and thrombolysis
  • Unveil the in-depth influencing factors leading to selection of specific pharmacological and interventional strategies

    • Table of Contents

    Other users found this report page using the following search terms: Acute Coronary Syndromes reperfusion therapy PCI percutaneous coronary intervention myocardial infarction thrombolysis acs acute coronary prevalence syndrome europe incidence uk stemi patients

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.